Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer

• Haoran Li,
• Zheng Liu,
• Shaoyi Chen,
• Jingsheng Cai,
• Peiyu Wang,
• Kezhong Chen,
• Mantang Qiu

Affiliations

Haoran Li

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China

Zheng Liu

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China

Shaoyi Chen

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China

Jingsheng Cai

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China

Peiyu Wang

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China

Kezhong Chen

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China

Mantang Qiu

Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Peking University People's Hospital Beijing China